Article Details
Retrieved on: 2024-09-13 20:54:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Currently, the only medicine approved in the U.S. for the treatment of TED is an intravenously infused human monoclonal antibody that blocks IGF1R.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here